Thorir Hardarson1, Mona Bungum2, Joe Conaghan3, Marius Meintjes4, Samuel J Chantilis4, Laszlo Molnar5, Kristina Gunnarsson6, Matts Wikland6. 1. Fertilitetscentrum, Carlanderska Hospital, Gothenburg, Sweden. Electronic address: thorir.hardarson@fertilitetscentrum.se. 2. Reproductive Medicine Centre, Skåne University Hospital, Malmö, Sweden. 3. Pacific Fertility Center, San Francisco, California. 4. Frisco Institute for Reproductive Medicine, Dallas/Austin, Texas. 5. MediBit Foundation, Budapest, Hungary. 6. Fertilitetscentrum, Carlanderska Hospital, Gothenburg, Sweden.
Abstract
OBJECTIVE: To study whether a culture medium that allows undisturbed culture supports human embryo development to the blastocyst stage equivalently to a well-established sequential media. DESIGN: Randomized, double-blinded sibling trial. SETTING: Independent in vitro fertilization (IVF) clinics. PATIENT(S): One hundred twenty-eight patients, with 1,356 zygotes randomized into two study arms. INTERVENTION(S): Embryos randomly allocated into two study arms to compare embryo development on a time-lapse system using a single-step medium or sequential media. MAIN OUTCOME MEASURE(S): Percentage of good-quality blastocysts on day 5. RESULT(S): Percentage of day 5 good-quality blastocysts was 21.1% (standard deviation [SD] ± 21.6%) and 22.2% (SD ± 22.1%) in the single-step time-lapse medium (G-TL) and the sequential media (G-1/G-2) groups, respectively. The mean difference (-1.2; 95% CI, -6.0; 3.6) between the two media systems for the primary end point was less than the noninferiority margin of -8%. There was a statistically significantly lower number of good-quality embryos on day 3 in the G-TL group [50.7% (SD ± 30.6%) vs. 60.8% (SD ± 30.7%)]. Four out of the 11 measured morphokinetic parameters were statistically significantly different for the two media used. The mean levels of ammonium concentration in the media at the end of the culture period was statistically significantly lower in the G-TL group as compared with the G-2 group. CONCLUSION(S): We have shown that a single-step culture medium supports blastocyst development equivalently to established sequential media. The ammonium concentrations were lower in the single-step media, and the measured morphokinetic parameters were modified somewhat. CLINICAL TRIAL REGISTRATION NUMBER: NCT01939626.
RCT Entities:
OBJECTIVE: To study whether a culture medium that allows undisturbed culture supports human embryo development to the blastocyst stage equivalently to a well-established sequential media. DESIGN: Randomized, double-blinded sibling trial. SETTING: Independent in vitro fertilization (IVF) clinics. PATIENT(S): One hundred twenty-eight patients, with 1,356 zygotes randomized into two study arms. INTERVENTION(S): Embryos randomly allocated into two study arms to compare embryo development on a time-lapse system using a single-step medium or sequential media. MAIN OUTCOME MEASURE(S): Percentage of good-quality blastocysts on day 5. RESULT(S): Percentage of day 5 good-quality blastocysts was 21.1% (standard deviation [SD] ± 21.6%) and 22.2% (SD ± 22.1%) in the single-step time-lapse medium (G-TL) and the sequential media (G-1/G-2) groups, respectively. The mean difference (-1.2; 95% CI, -6.0; 3.6) between the two media systems for the primary end point was less than the noninferiority margin of -8%. There was a statistically significantly lower number of good-quality embryos on day 3 in the G-TL group [50.7% (SD ± 30.6%) vs. 60.8% (SD ± 30.7%)]. Four out of the 11 measured morphokinetic parameters were statistically significantly different for the two media used. The mean levels of ammonium concentration in the media at the end of the culture period was statistically significantly lower in the G-TL group as compared with the G-2 group. CONCLUSION(S): We have shown that a single-step culture medium supports blastocyst development equivalently to established sequential media. The ammonium concentrations were lower in the single-step media, and the measured morphokinetic parameters were modified somewhat. CLINICAL TRIAL REGISTRATION NUMBER: NCT01939626.
Authors: Ioannis A Sfontouris; Efstratios M Kolibianakis; George T Lainas; Christos A Venetis; George K Petsas; Basil C Tarlatzis; Tryfon G Lainas Journal: J Assist Reprod Genet Date: 2017-07-17 Impact factor: 3.412
Authors: Ioannis A Sfontouris; Wellington P Martins; Carolina O Nastri; Iara G R Viana; Paula A Navarro; Nick Raine-Fenning; Sheryl van der Poel; Laura Rienzi; Catherine Racowsky Journal: J Assist Reprod Genet Date: 2016-08-05 Impact factor: 3.412
Authors: Danilo Cimadomo; C Scarica; R Maggiulli; G Orlando; D Soscia; L Albricci; S Romano; F Sanges; F M Ubaldi; L Rienzi Journal: J Assist Reprod Genet Date: 2018-05-03 Impact factor: 3.412
Authors: Felipe Dieamant; Claudia G Petersen; Ana L Mauri; Vanessa Comar; Marina Mattila; Laura D Vagnini; Adriana Renzi; Bruna Petersen; Juliana Ricci; João Batista A Oliveira; Ricardo L R Baruffi; Jose G Franco Journal: JBRA Assist Reprod Date: 2017-09-01
Authors: Caitlin R Sacha; Daksha Gopal; Chia-Ling Liu; Howard R Cabral; Judy E Stern; Daniela A Carusi; Catherine Racowsky; Charles L Bormann Journal: Fertil Steril Date: 2022-04-23 Impact factor: 7.490
Authors: Susanna Apter; Thomas Ebner; Thomas Freour; Yves Guns; Borut Kovacic; Nathalie Le Clef; Monica Marques; Marcos Meseguer; Debbie Montjean; Ioannis Sfontouris; Roger Sturmey; Giovanni Coticchio Journal: Hum Reprod Open Date: 2020-03-19